Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 6765 (MIR6765) is a predicted non-coding RNA gene classified as a microRNA (miRNA), a short (20–24 nucleotides) sequence involved in the post-transcriptional regulation of gene expression in multicellular organisms[4]. Like other miRNAs, MIR6765 is transcribed as part of a primary miRNA (pri-miRNA) transcript, processed to a hairpin precursor (pre-miRNA), and finally cleaved to produce a mature miRNA sequence. These mature miRNAs are incorporated into the RNA-induced silencing complex (RISC), where they guide the complex to target mRNAs by imperfect base pairing, leading to inhibition of translation or destabilization of the target transcript[4]. There is currently no information linking MIR6765 to specific biological functions, disease roles, or therapeutic targeting. It is one of the many miRNAs catalogued based on sequence but lacks annotated experimental or clinical associations to date[4].
Not applicable (no approved drugs or experimental modulators identified)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 6765 (MIR6765).